Considerable overlap between HIV and shigellosis epidemics in the UK
Online privacy concerns limit the reach of sexual health messages on social media
Multiple social and health factors associated with irregular attendance at London HIV clinics
DAAs achieve excellent outcomes in real-world settings
Model suggests there are fewer people with HIV in the US than thought, and more of them on therapy
High incidence of HCV reinfection among HIV-positive MSM in Western Europe
Sofosbuvir/velpatasvir cures HCV in 95% of people with HCV and HIV co-infection
Six weeks of sofosbuvir/ledipasvir is enough to cure acute hepatitis C in HIV-negative people
Tenofovir alafenamide works well against hepatitis B with less effect on bones and kidneys
